Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Nucleolus02:55

The Nucleolus

10.7K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.7K
Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differences in Primary Molecular Subtype Distribution Contribute to Racial and Ethnic Disparities in Adult-Type Diffuse Gliomas.

Neuro-oncology·2026
Same author

Early Findings from the Multicenter RAPID Consortium on Papillary Craniopharyngiomas.

Journal of neurological surgery. Part B, Skull base·2026
Same author

Comparison of clinical outcomes in adamantinomatous and papillary craniopharyngioma: a baseline analysis before the targeted therapy era.

Neurosurgical focus·2026
Same author

Predictors of hospital length of stay, discharge disposition, and readmission after craniopharyngioma surgery: a multicenter study from the RAPID database.

Neurosurgical focus·2026
Same author

Frailty and postoperative outcomes following craniopharyngioma resection: a multicenter Registry for Adenomas of the Pituitary and Related Disorders analysis.

Neurosurgical focus·2026
Same author

Risk factors for postoperative cerebrospinal fluid leak following endoscopic transsphenoidal surgery for craniopharyngioma: a multicenter cohort study with a contemporary surgeon practice survey.

Journal of neuro-oncology·2026

Related Experiment Video

Updated: Apr 6, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

20.1K

Gene expression in prolactinomas: a systematic review.

Justin Seltzer1, Thomas C Scotton2, Keiko Kang3

  • 1Department of Neurosurgery, Keck School of Medicine of USC, 1200 North State St., Los Angeles, CA, 90033, USA. jseltzer@usc.edu.

Pituitary
|August 5, 2015
PubMed
Summary

This study identifies key genes in prolactinomas, the most common pituitary tumors. These molecular markers offer potential for new diagnostic tools and targeted therapies for treatment-resistant cases.

Keywords:
Gene expressionLactotrophPituitary adenomaProlactinProlactinomaProtein expression

More Related Videos

X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models
12:57

X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models

Published on: December 9, 2022

2.9K
Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome
12:34

Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome

Published on: April 2, 2018

14.2K

Related Experiment Videos

Last Updated: Apr 6, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

20.1K
X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models
12:57

X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models

Published on: December 9, 2022

2.9K
Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome
12:34

Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome

Published on: April 2, 2018

14.2K

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Prolactinomas are common functional pituitary adenomas.
  • Current classifications lack molecular markers.
  • Treatment options are limited for refractory cases.

Purpose of the Study:

  • To review gene and protein expression in prolactinomas.
  • To identify molecular variations linked to tumor development and function.
  • To highlight potential therapeutic and diagnostic targets.

Main Methods:

  • Systematic literature review following PRISMA guidelines.
  • PubMed search for gene and protein expression studies (1990-2014).
  • Analysis of identified upregulated and downregulated genes.

Main Results:

  • 51 studies analyzed, identifying 54 upregulated and 95 downregulated genes.
  • Key upregulated genes: HMGA2, HST, SNAP25.
  • Key downregulated genes: UGT2B7, Let7, miR-493.

Conclusions:

  • Numerous significant genes identified in prolactinomas.
  • These genes hold potential for biomarker development.
  • Further research can advance precision medicine for prolactinomas.